Susquehanna International Group’s Can-Fite BioPharma CANF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,047
| Closed | -$31.9K | – | 5995 |
|
|
2023
Q3 | $31.9K | Buy |
+12,047
| New | +$31.9K | ﹤0.01% | 5203 |
|
|
2023
Q1 | – | Sell |
-3,274
| Closed | -$20.1K | – | 6043 |
|
|
2022
Q4 | $20.1K | Sell |
3,274
-2,663
| -45% | -$16.3K | ﹤0.01% | 5367 |
|
|
2022
Q3 | $46K | Buy |
5,937
+1,270
| +27% | +$9.84K | ﹤0.01% | 5516 |
|
|
2022
Q2 | $43K | Buy |
+4,667
| New | +$43K | ﹤0.01% | 5269 |
|
|
2021
Q1 | – | Sell |
-1,532
| Closed | -$27K | – | 5216 |
|
|
2020
Q4 | $27K | Buy |
+1,532
| New | +$27K | ﹤0.01% | 4669 |
|
|
2019
Q4 | – | Sell |
-4,916
| Closed | -$101K | – | 4068 |
|
|
2019
Q3 | $101K | Buy |
+4,916
| New | +$101K | ﹤0.01% | 4078 |
|
|
2018
Q4 | – | Sell |
-86
| Closed | -$17K | – | 3757 |
|
|
2018
Q3 | $17K | Sell |
86
-196
| -70% | -$38.7K | ﹤0.01% | 3193 |
|
|
2018
Q2 | $50K | Buy |
+282
| New | +$50K | ﹤0.01% | 3414 |
|
|
2015
Q4 | – | Sell |
-93
| Closed | -$58K | – | 4250 |
|
|
2015
Q3 | $58K | Buy |
+93
| New | +$58K | ﹤0.01% | 4026 |
|
|
2014
Q4 | – | Sell |
-67
| Closed | -$33K | – | 4404 |
|
|
2014
Q3 | $33K | Sell |
67
-1,418
| -95% | -$698K | ﹤0.01% | 3785 |
|
|
2014
Q2 | $795K | Sell |
1,485
-462
| -24% | -$247K | ﹤0.01% | 2680 |
|
|
2014
Q1 | $1.47M | Buy |
+1,947
| New | +$1.47M | ﹤0.01% | 1765 |
|